Bacterial keratitis

角膜炎 眼科 医学 验光服务 皮肤病科
作者
László Módis
出处
期刊:Acta Ophthalmologica [Wiley]
卷期号:103 (S284)
标识
DOI:10.1111/aos.16835
摘要

The number of infectious keratitis cases is increasing worldwide. The vast majority of cases are bacterial in origin. Both gram positive (Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pneumoniae Corynebacterium diphtheriae) and gram negative (Pseudomonas aeruginosa, Acinetobacter species) bacteria can cause serious infections. One of the most common causes is related to contact lens wear. This can be in connection with overwear, overnight wear (orthokeratology), inadequate lens cleaning with tap water, lack of hygiene, and contamination of different solutions. Uncontrolled use of lenses ordered from the internet is also a source of danger. The other main cause is trauma, resulting from surface injuries (e.g. nails, plants), foreign bodies, mechanical and chemical injuries. Certain ophthalmological conditions also predispose to bacterial keratitis, such as dry eye, blepharitis, non‐healing ulceration, and previous eye surgery. Immunosuppressive treatment, autoimmune diseases, diabetes mellitus may also result in development of infection. In serious cases patients typically complain of pain, sensitivity to light, blurred vision, tearing, yellowish purulent discharge and various degree of visual loss. Clinical appearance includes epithelial defect and erosions, ulceration, stromal infiltrates with indistinct margins. In serious forms Descemetocele, even perforation can be present. Hypopyon may also appear in the anterior chamber. Diagnosis is based on the clinical picture. Culturing and smear sampling are necessary when the infiltrate is large and central, when there in contact lens wear in the history, the process is resistant to therapy, and appearance is atypical. Most cases can be successfully treated with empiric therapy. The first choice of treatment is usually fluroquinolone therapy. In severe cases moxifloxacin or cefazolin with tobramycin or gentamycin is advised. Eye drops in every hour should be applied both day and night for the first 48 hours as saturation dose. If there is no improvement in the clinical picture after 48 hours, repeat sampling for microbiological culture recommended. Corticosteroids may be considered after 2 days when the infective organism is identified, and the keratitis is responding to therapy. Cycloplegia may also decrease pain as well as synechia formation. In therapy resistant cases crosslinking may be an additional option if herpetic origin can be excluded. Amniotic membrane transplantation is recommended for non‐healing epithelial defects. In cases of non‐healing and rapidly progressive cases therapeutic corneal transplantation is recommended. However, surgery has a better prognosis in quiet eye.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
阳光的鲂完成签到,获得积分10
刚刚
1秒前
1秒前
焚天尘殇完成签到,获得积分10
1秒前
栗子发布了新的文献求助10
2秒前
2秒前
稳重伊完成签到,获得积分10
2秒前
77发布了新的文献求助10
2秒前
2秒前
2秒前
黎明发布了新的文献求助10
3秒前
aaaa发布了新的文献求助10
3秒前
ldk完成签到,获得积分10
3秒前
4秒前
4秒前
无花果应助1234采纳,获得10
5秒前
6秒前
善学以致用应助yyyzzz采纳,获得10
6秒前
7秒前
Endless发布了新的文献求助10
7秒前
Wlin发布了新的文献求助10
8秒前
宛海发布了新的文献求助10
8秒前
英俊的铭应助梦酱采纳,获得10
8秒前
8秒前
9秒前
10秒前
10秒前
10秒前
11秒前
代何完成签到,获得积分10
11秒前
111完成签到 ,获得积分10
11秒前
11秒前
你好发布了新的文献求助10
11秒前
沐芷澄发布了新的文献求助30
12秒前
12秒前
自然发布了新的文献求助10
13秒前
Yolanda_Xu完成签到 ,获得积分10
14秒前
15秒前
lxaiczn发布了新的文献求助10
15秒前
JK_Xu发布了新的文献求助10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Kinesiophobia : a new view of chronic pain behavior 2000
Cronologia da história de Macau 1600
Earth System Geophysics 1000
Bioseparations Science and Engineering Third Edition 1000
Lloyd's Register of Shipping's Approach to the Control of Incidents of Brittle Fracture in Ship Structures 1000
BRITTLE FRACTURE IN WELDED SHIPS 1000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 物理 生物化学 化学工程 计算机科学 复合材料 内科学 催化作用 光电子学 物理化学 电极 冶金 遗传学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 6126516
求助须知:如何正确求助?哪些是违规求助? 7954465
关于积分的说明 16504093
捐赠科研通 5246034
什么是DOI,文献DOI怎么找? 2801860
邀请新用户注册赠送积分活动 1783200
关于科研通互助平台的介绍 1654389